Spyre Therapeutics (SYRE) Share-based Compensation (2015 - 2026)
Spyre Therapeutics (SYRE) recorded Share-based Compensation of $14.17 million in Q3 2026, up 48.1% from $9.57 million a year earlier and up 4.8% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Share-based Compensation (2015 - 2026) Analysis & Trends
On a TTM basis, Spyre Therapeutics' Share-based Compensation came in at $50.3 million as of Sep 30, 2026, up 35.9% year-over-year; for FY2025, it was $37.61 million, down 16.1% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 43.2% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $44.83 million in FY2024 (+74.6%), $25.68 million in FY2023 (+261.1%), $7.11 million in FY2022 (-11.5%) and $8.04 million in FY2021 (+28.5%).
- The Q3 2026 figure is the highest quarterly Share-based Compensation since Q4 2023.
- On a year-over-year basis, Share-based Compensation has increased for four consecutive quarters, with growth averaging 5.2% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 709.5% in Q1 2024, against a decline of 46.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $13.51 million (Q2 2026), $12.81 million (Q1 2026) and $9.81 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Spyre Therapeutics | 9.45 Bn | 5.73 Bn | - | 14.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.17 Mn |
| Jun 30, 2026 | 13.51 Mn |
| Mar 31, 2026 | 12.81 Mn |
| Dec 31, 2025 | 9.81 Mn |
| Sep 30, 2025 | 9.57 Mn |
| Jun 30, 2025 | 9.38 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Dec 31, 2024 | 9.22 Mn |
| Sep 30, 2024 | 13.10 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 13.84 Mn |
| Dec 31, 2023 | 17.27 Mn |
| Sep 30, 2023 | 4.80 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.57 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 2.09 Mn |
API Access
Spyre Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();